Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
ABL, Inc. is a CDMO and CRO providing GMP manufacturing and immunology solutions for gene therapies, oncolytics, vaccines and other immunotherapeutics. We specialize in immuno-oncology, infectious diseases, neurological diseases and chronic diseases. ABL has a global footprint, with facilities in the U.S. and Europe, offering integrated product development platforms for GMP virus and protein manufacture, bioanalytical services, biomarker identification and immunological testing. Please visit us at www.ablinc.com and email us at info@ablinc.com to discuss how we can help advance your innovative therapies and vaccines with a revolutionary partnership!
Agenda
- US Viral Vector Capabilities
- European Viral Vector Capabilities
- Global Immunology and Testing Services
Language:
English
Who can attend? Everyone
Featured Presenters
Sales Manager, Biomanufacturing
Technical Sales Manager here to help plan your cell and gene therapy manufacturing projects. Let’s discuss a partnership with ABL!
Sales Manager, Immunology
Scientist-turned-sales manager. From biomarker detection to cellular assays, I can help you find the right immunology research support for your therapies.
VP, Immunology
Immunology guru. My staff of experts and I can support you from the bench to the clinic.
Director, Process Development
An ABL leader looking to join forces for a powerful partnership on virus vector development and manufacturing. Lets discuss today how can we bring your innovation to the clinic.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.